NervoLyn
NervoLyn lists alpha-lipoic acid in a 575 mg proprietary blend but does not disclose its individual dose.
Verify the current bottle label, price, shipping, and return terms on the seller's page.Ingredient profile · Updated July 27, 2026
Alpha-Lipoic Acid: evidence, safety, and supplement-label guide
Also known as: ALA; thioctic acid
Alpha-lipoic acid has been studied for diabetic neuropathy, but reviews have reached mixed conclusions. Ingredient research does not establish the effect of an undisclosed amount in NervoLyn.
Buyer takeaway
A supplement that identifies Alpha-Lipoic Acid clearly, discloses the relevant form and amount, and shows the complete serving is easier to compare. We found one reviewed product that can help you put those checks into practice.
Buyer shortcut
Shopping for a supplement with Alpha-Lipoic Acid?
The ingredient name gets a product onto your shortlist. The label, amount, formula transparency, package value, and seller terms determine whether it deserves to stay there. Right From Shelf has already reviewed a product that list Alpha-Lipoic Acid.
Affiliate disclosure: We may earn a commission if you purchase through an offer link below, at no extra cost to you.
What is Alpha-Lipoic Acid?
Alpha-lipoic acid is a compound made in the body and used in energy metabolism. Supplements provide it as a separate ingredient, sometimes in racemic or R-ALA forms.
What does the evidence actually show?
NCCIH describes inconsistent findings for diabetic neuropathy: some analyses suggest possible pain reduction, while others found no benefit. Dose, route, duration, and population vary, and no located trial tested the finished NervoLyn formula.
Evidence boundary
Research on an isolated ingredient does not prove that a finished supplement works. The form, dose, duration, population, other ingredients, and measured outcome must be comparable.
Safety and interaction considerations
ALA can cause digestive symptoms and may affect blood glucose. People using diabetes medicines or managing thyroid conditions should discuss suitability and monitoring with a qualified clinician.
Dietary supplements can interact with medicines and may not be appropriate during pregnancy, nursing, before surgery, or with certain health conditions. This page provides general information, not individualized medical advice.
How to evaluate it on a Supplement Facts label
- How many milligrams of ALA are delivered daily?
- Does the label identify standard ALA or R-ALA?
- Is the disclosed dose comparable with the cited human research?
If the ingredient sits inside a proprietary blend, the total blend weight does not reveal the ingredient's individual dose. That uncertainty prevents a reliable comparison with most clinical research.
Smart purchase check
A buyer-friendly Alpha-Lipoic Acid product should make three things easy
The species, plant part, compound, or extract should be specific enough to compare.
An individual daily amount is more useful than an ingredient name hidden inside a proprietary blend.
Serving count, total price, shipping, subscription status, and written return terms should be visible before payment.
Frequently asked questions
What is Alpha-Lipoic Acid?
Alpha-lipoic acid is a compound made in the body and used in energy metabolism. Supplements provide it as a separate ingredient, sometimes in racemic or R-ALA forms.
What does the evidence show about Alpha-Lipoic Acid?
NCCIH describes inconsistent findings for diabetic neuropathy: some analyses suggest possible pain reduction, while others found no benefit. Dose, route, duration, and population vary, and no located trial tested the finished NervoLyn formula.
What should buyers check on a Alpha-Lipoic Acid label?
How many milligrams of ALA are delivered daily? Does the label identify standard ALA or R-ALA? Is the disclosed dose comparable with the cited human research?
Sources
- NCCIH: Diabetes and Dietary Supplements.
- PubMed: Cochrane review of ALA for diabetic peripheral neuropathy.
By Right From Shelf Editorial Team · General information, not medical advice · Reviewed July 27, 2026